dextroamphetamine has been researched along with Heart Septal Defects, Ventricular in 2 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nora, JJ | 2 |
| Sommerville, RJ | 1 |
| Fraser, FC | 1 |
2 other studies available for dextroamphetamine and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
Etiologic factors in congenital heart diseases.
Topics: Animals; Child, Preschool; Chromosome Aberrations; Counseling; Dextroamphetamine; Diseases in Twins; | 1971 |
Homologies for congenital heart diseases: murine models, influenced by dextroamphetamine.
Topics: Animals; Dextroamphetamine; Disease Models, Animal; Female; Heart Septal Defects, Atrial; Heart Sept | 1968 |